The oral antiviral medication Favipiravir, which prevents the replication phase of the virus life-cycle, leads to significant improvement in clinical cure in patients with ... Nov 23
Glenmark the first company to launch Favipiravir in India now launches 400 mg tablets... Aug 06
Avigan to give a hard fight to other favipiravir brands while making the drug more accessible... Jul 14
Glenmark has also completed the phase 3 clinical trial with Favipiravir (FabiFlu) in mild to moderate COVID-19 patients in India... Jul 13
Many experts said the drug was not only expensive but it was still under trial in most countries and its efficacy was yet to be ... Jun 23
After Glenmark, Cipla is ready with their version of cheaper Favipiravir... Jun 22
Glenmark is the first pharmaceutical company in India to receive approval for antiviral Favipiravir for mild to moderate covid patients... Jun 20
COVID-19 patients from over 10 leading government and private hospitals in India are being enrolled for the study. Trial completion and study results expected ... May 12
-Advertisements-
Saturday, June 15, 2024
